Skip to main content
. 2015 Jan 31;6(8):6267–6280. doi: 10.18632/oncotarget.3365

Table 3. Hazard ratios for CD133-M and CD44-M GBM subtypes by treatment.

Subtype Treatment Hazard ratio (95% CI) p-value
CD133-M Temozolomide 0.722 (0.474 to 1.097) 0.127
CD133-M Radiation 0.287 (0.173 to 0.477) 1.36e-6
CD44-M Temozolomide 0.615 (0.416 to 0.908) 0.0145
CD44-M Radiation 0.512 (0.298 to 0.880) 0.154